Report of FDA Approved Commercial Products Involving NIH Extramural Support

Items listed on this page have been identified as having involved NIH extramural support that helped to further the research and development of these final products. Although each product may have multiple funding sources and may include multiple technologies, the products are listed because NIH extramural support was also identified as being involved.

Please note that the time for development of a successful FDA approved drug, from basic research and initial identification of a potential candidate compound through to FDA approval, can range from 5 years to 15 years.

Commercial NameFDA Approval TypeFDA Approval NumberNIH Support
Active Contact System HD036154
HD036154
AldurazymeBiologic125058AI013526
BexxarBiologicBL 125011/0CA042768
BiologicBL 125011/0CA056794
BisBlock (TM) DE006427
Emtriva (CAPSULE; ORAL 200MG)Drug021500AI026055
Drug021500AI026055
Drug021500AI028731
Drug021500AI028731
Emtriva (SOLUTION; ORAL 10MG/ML)Drug021896AI026055
Drug021896AI026055
Drug021896AI028731
Drug021896AI028731
EndoWave Peripheral Infusion SystemMedical DeviceKO72507R44 HL057739
EpzicomDrug021652AI026055
Drug021652AI028731
Estramet CA022795
Fel-O-Vax FIV AI030904
FluMistBiologicBL 125020/43AI005053
BiologicBL 125020/43AI020591
BiologicBL 125020/43AI021765
BiologicBL 125020/43AI052564
BiologicBL 125020/43AI072521
BiologicBL 125020/43CA021765
BiologicBL 125020/43RR004154
GEM 21SMedical DeviceP040013DE007010
GEMS 21Medical DeviceP040013DE007010
Hylenex RecombinantDrug021859AI013526
ImageCheckerMedical DeviceP030012CA024806
Medical DeviceP030012CA048985
Medical DeviceP030012CA062625
Medical DeviceP030012CA064370
Medical DeviceP030012CA079711
Medical DeviceP030012CA089452
Medical DeviceP030012RR011459
LyricaDrug021446NS015703
MenostarDrugNDA# 021674AG005407
ONTAKBiologic1258AI012500
Biologic1258AM016684
OrenciaDrug125118AI013526
Plenaxis HD033172
ProKera (TM)Medical DeviceK032104R01 EY006819
ProKera (TM) Ophthalmic Conformer R01 EY006819
RapidScreenMedical DeviceP000041CA024806
RestasisDrug50-790EY005720
Trusopt EY002227
Trusopt & Cosopt EY002227
TruvadaDrug021752AI026055
Drug021752AI028731
TysabriBiologic125104AI013526
UDP-Glycuronosyl Transferase 1A 1TA Repeat Genotype, UGT1A1Medical DeviceK051824CA014599
Medical DeviceK051824CM007301
ZeritDrug CA028852
ZolinzaDrugNDA 21-991CA057227


Commercial NameSupport
Epogen
KaletraAI027220
Neupogen
NorvirAI027220
Procrit
Taxol
TruvadaAI026055
AI028731
XalatanEY000333
EY000402
ZeritCA028852

Home | About | Help
E-mail the NIH administrator | OMB Burden Statement | iEdison Privacy Notice